Table 2.
Biochemical parameters in all experimental groups
| Parameter | Control | Sham | LD-ETP | MD-ETP | HD-ETP | Neostigmine |
|---|---|---|---|---|---|---|
| Serum AChE (mU mL -1 ) | 0.34 ± 0.00a | 0.32 ± 0.00a | 0.25 ± 0.01b | 0.22 ± 0.00bc | 0.18 ± 0.00c | 0.25 ± 0.01b |
| Blood AChE (mU mL -1 ) | 0.67 ± 0.01ab | 0.69 ± 0.01a | 0.62 ± 0.01b | 0.35 ± 0.01d | 0.21 ± 0.00e | 0.50 ± 0.01c |
| Catalase activity (U mg -1 ) | 502.20 ± 1.12a | 503.90 ± 1.45a | 405.60 ± 1.65b | 370.50 ± 3.10b | 303.30 ± 1.01c | 404.10 ± 2.22b |
| Testicular TAC (mmol g -1 ) | 2.32 ± 0.00a | 2.47 ± 0.07a | 1.88 ± 0.05b | 1.38 ± 0.03c | 0.92 ± 0.02d | 1.91 ± 0.03b |
| Testicular MDA (nmol g -1 ) | 13.42 ± 0.10d | 13.52 ± 0.09d | 13.86 ± 0.06c | 20.76 ± 0.06b | 23.05 ± 0.01a | 14.03 ± 0.01c |
| Serum TAC (µmol L -1 ) | 4.03 ± 0.01a | 3.87 ± 0.06a | 3.22 ± 0.06b | 2.50 ± 0.10c | 1.70 ± 0.14d | 2.78 ± 0.10bc |
| Serum MDA (µmol L -1 ) | 5.54 ± 0.12c | 5.23 ± 0.09c | 5.52 ± 0.22c | 6.44 ± 0.18b | 7.46 ± 0.26a | 5.56 ± 0.14c |
| Testosterone (ng mL -1 ) | 0.29 ± 0.07a | 0.43 ± 0.11a | 0.31 ± 0.01a | 0.23 ± 0.01a | 0.19 ± 0.01a | 0.32 ± 0.01a |
LD-ETP: Low dose ethephon (120 mg kg-1); MD-ETP: Mid-dose ethephon (240 mg kg-1); HD-ETP: High dose ethephon (480 mg kg-1); AChE: Acetylcholinesterase; TAC: Total antioxidant capacity; MDA: Malondialdehyde.
abcde Different letters indicate significant difference among groups (p < 0.05).